209 related articles for article (PubMed ID: 31135037)
1. Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis.
Fan N; Yang H; Zheng J; Chen D; Wang W; Tan Z; Huang Y; Lin P
Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):434-441. PubMed ID: 31135037
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival.
Koterazawa Y; Oshikiri T; Takiguchi G; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Fujino Y; Tominaga M; Suzuki S; Kakeji Y
Ann Surg Oncol; 2019 Sep; 26(9):2899-2904. PubMed ID: 31187365
[TBL] [Abstract][Full Text] [Related]
3. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Zhou J; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Jia H; Cheng X; Li H; Zhang Y; Li C; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
Ann Surg; 2018 May; 267(5):826-832. PubMed ID: 28448385
[TBL] [Abstract][Full Text] [Related]
4. Three-field versus two-field lymphadenectomy in transthoracic oesophagectomy for oesophageal squamous cell carcinoma: short-term outcomes of a randomized clinical trial.
Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Li H; Zhang Y; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
Br J Surg; 2020 May; 107(6):647-654. PubMed ID: 32108326
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma.
Shim YM; Kim HK; Kim K
J Thorac Oncol; 2010 May; 5(5):707-12. PubMed ID: 20421764
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
[TBL] [Abstract][Full Text] [Related]
7. Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.
Yamashita K; Makino T; Yamasaki M; Tanaka K; Hara T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881906
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.
Chen JY; Liu QW; Zhang SS; Li JB; Yang H; Wen J; Fu JH
J Surg Oncol; 2020 Aug; 122(2):336-343. PubMed ID: 32410255
[TBL] [Abstract][Full Text] [Related]
9. Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes.
Deng HY; Luo J; Li SX; Li G; Alai G; Wang Y; Liu LX; Lin YD
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30496378
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma.
Matsuda S; Kawakubo H; Takeuchi H; Hayashi M; Mayanagi S; Takemura R; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
Br J Surg; 2020 May; 107(6):705-711. PubMed ID: 32077101
[TBL] [Abstract][Full Text] [Related]
11. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
[TBL] [Abstract][Full Text] [Related]
12. A Propensity Score-Matched Analysis of Thoracolaparoscopic vs Open McKeown's Esophagectomy.
Wang K; Zhong J; Liu Q; Lin P; Fu J
Ann Thorac Surg; 2022 Feb; 113(2):473-481. PubMed ID: 33621558
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis.
Yamashita K; Watanabe M; Mine S; Toihata T; Fukudome I; Okamura A; Yuda M; Hayami M; Ishizuka N; Imamura Y
Surg Endosc; 2018 Nov; 32(11):4443-4450. PubMed ID: 29644466
[TBL] [Abstract][Full Text] [Related]
14. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
16. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
[TBL] [Abstract][Full Text] [Related]
18. Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment?
Yuan X; Lv J; Dong H; Wang J
Interact Cardiovasc Thorac Surg; 2017 May; 24(5):792-795. PubMed ID: 28453803
[TBL] [Abstract][Full Text] [Related]
19. Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
Du R; Fan S; Yang D; Wang X; Hou X; Zeng C; Guo D; Tian R; Jiang L; Dong X; Yu R; Yu H; Zhu S; Li J; Shi A
BMC Cancer; 2024 May; 24(1):596. PubMed ID: 38755542
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
